ABCB1 and Alzheimer disease: Since reducing ABC transporter activity could exacerbate conditions such as Alzheimer’s disease, including prodromal stages, where ABCB1 activity is critical for clearance of Aβ from the brain, chronic downregulation of ABC transporters could bear risks.